Value-Based Care
Value-based care is the shift from paying for volume of services to paying for outcomes and total cost of care. In home health, the most direct expression is the expanded Home Health Value-Based Purchasing (HHVBP) model, which adjusts Medicare payments up or down based on quality performance. Value-based pressure also reaches agencies through accountable care organizations, Medicare Advantage plans, and bundled payment arrangements.
HHVBP: value-based care with teeth
The expanded HHVBP model has applied nationwide to Medicare-certified home health agencies since 2023, with the first payment adjustments hitting in CY2025. Agencies earn a Total Performance Score (TPS) based on quality measures scored against cohort benchmarks, and the TPS drives a payment adjustment of up to plus or minus 5% of Medicare fee-for-service payments. For CY2026, OASIS-based measures carry 40% of the TPS, including new bathing and dressing function measures; claims-based measures carry 40%, including a new Medicare Spending Per Beneficiary Post-Acute Care measure; and HHCAHPS carries 20%, with only two survey measures remaining, Overall Rating and Willingness to Recommend, at 10% each. A 5% swing on Medicare revenue is the difference between a healthy margin and a loss for many agencies.
Value-based pressure beyond HHVBP
HHVBP is the mandatory floor, but most value-based exposure arrives through partners. Accountable care organizations (ACOs) bear total cost of care risk and favor home health agencies that reduce hospitalizations and support discharge to community. Hospitals in bundled payment models need post-acute partners who deliver episodes under target prices. Medicare Advantage plans increasingly build quality expectations and utilization management into contracts, and some offer upside for readmission performance. In each case the agency may not sign a risk contract itself, but its outcomes data determines whether it stays in the partner's network. Value-based care thus shapes referral flow even for agencies paid entirely fee-for-service.
What value-based success requires operationally
The capabilities are consistent across programs:
- OASIS accuracy, because assessment data drives both measured outcomes and risk adjustment
- Hospitalization prevention: timely starts, front-loaded visits, medication reconciliation, red-flag teaching
- Patient experience management, since HHCAHPS carries real weight in HHVBP and star ratings
- Cost discipline per episode, as spending-based measures and partner economics reward efficiency
- Data infrastructure to track performance monthly instead of discovering it in lagged CMS reports
None of these are new virtues. What value-based care changes is that they now have a price attached.
Common pitfalls
The classic mistake is treating value-based care as a QA department project rather than an operating model, leaving schedulers, intake staff, and field clinicians disconnected from the measures their daily decisions move. Another is ignoring HHCAHPS: at 20% of the CY2026 TPS, patient experience is too heavy to treat as an afterthought, and with only two measures remaining, each one carries 10% on its own. Agencies also fail to model the financial stakes, discovering the size of a negative adjustment only when it lands. Finally, beware of improving against your own baseline while your cohort improves faster; HHVBP scores you against benchmarks, not against your past self alone.
Frequently asked questions
How much money is at stake under HHVBP?
Payment adjustments run up to plus or minus 5% of an agency's Medicare fee-for-service payments, based on the Total Performance Score. The first adjustments took effect in CY2025. For an agency with $10 million in Medicare revenue, the spread between best and worst case is up to $1 million a year.
Is value-based care only a Medicare fee-for-service issue?
No. HHVBP applies to Medicare FFS payments, but ACOs, bundled payment participants, and Medicare Advantage plans all bring value-based expectations to their home health partners. Agencies with heavy MA or ACO-attributed populations often feel more value-based pressure through contracting and network decisions than through HHVBP itself.
Which measures count in HHVBP for 2026?
The CY2026 measure set weights OASIS-based measures at 40% of the Total Performance Score, including new bathing and dressing function measures, claims-based measures at 40%, including a new Medicare Spending Per Beneficiary Post-Acute Care measure, and HHCAHPS at 20%, split evenly between Overall Rating and Willingness to Recommend.